Introducing iBreathezy, an innovative pediatric tool designed to revolutionize the management of asthma in children. Recognizing the challenge that many young patients face in properly administering their asthma medication, iBreathezy aims to bridge the gap between treatment and effective usage. Often, children may not fully understand how to use inhalers correctly, leading to suboptimal health outcomes. Traditional training methods, while helpful, lack objective measures to ensure that children are using their devices properly.
iBreathezy addresses this critical pain point by providing real-time feedback on lung capacity and airflow. This modern device measures how much air a child inhales and exhales, as well as the speed of their exhalation. By offering objective data, iBreathezy empowers children and their caregivers to understand their lung health better and ensures that they are using their asthma medications effectively.
The device has undergone two successful clinical trials, demonstrating its efficacy in improving asthma management among pediatric patients. With intellectual property pending, iBreathezy is poised for future growth and development, and licensing opportunities are welcomed.
Benefits of iBreathezy:
With iBreathezy, children can take charge of their respiratory health, ensuring they receive the full benefits of their asthma treatment and paving the way for a healthier future.
Stay Healthy With
© 2025 SingHealth Group. All Rights Reserved.